SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-19-000063
Filing Date
2019-11-12
Accepted
2019-11-12 16:16:33
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq32019.htm 10-Q 1018848
2 EXHIBIT 31.1 exhibit311q32019.htm EX-31.1 14032
3 EXHIBIT 31.2 exhibit312q32019.htm EX-31.2 14051
4 EXHIBIT 32.1 exhibit321q32019.htm EX-32.1 8148
  Complete submission text file 0001561743-19-000063.txt   6740334

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kin-20190930.xml EX-101.INS 1698029
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20190930.xsd EX-101.SCH 41565
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20190930_cal.xml EX-101.CAL 84214
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20190930_def.xml EX-101.DEF 212848
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20190930_lab.xml EX-101.LAB 598322
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20190930_pre.xml EX-101.PRE 363943
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 191209638
SIC: 2834 Pharmaceutical Preparations